Breast tumor xenografts of luminal subtype switch to the ERBB2+molecular subtype in response to endocrine therapy: Gene expression profiling may not predict pathways of resistance in pretreatment tumors

被引：0

|

作者：

Creighton, Chad J. ^{[1
]}

Massarweh, Suleiman ^{[2
]}

Huang, Shixia ^{[1
]}

Tsimelzon, Anna ^{[1
]}

Hilsenbeck, Susan G. ^{[1
]}

Osborne, C. K. ^{[1
]}

Schiff, Rachel ^{[1
]}

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Univ Kentucky, Lexington, KY USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：3484S / 3485S

页数：2

相关论文

共 2 条

[1] NUPR1 contributes to endocrine therapy resistance by modulating BIRC5 expression and inducing luminal B-ERBB2+ subtype-like characteristics in estrogen breast cancer cells
Lee, Chun-Hui
Lin, Yi-Chen
Chang, Yung-Chieh
Chen, Pin-Chen
Lin, Kai-Hsuan
Yeh, Tzu-Miao
Leung, Euphemia Yee
Lin, I. -Li
Chen, Shang-Hung
Cheung, Chun Hei Antonio
JOURNAL OF CANCER, 2025, 16 (05): : 1694 - 1708
[2] RNA-Seq based gene expression profiling of baseline and on-treatment breast tumors to predict response to HER2-directed therapy, without chemotherapy (TBCRC026)
Hennessy, Maeve
Fernandez, Aranzazu
Huang, Chiung Yu
Cimino-Mathews, Ashley
Denbow, Rita
Abramson, Vandana G.
Rimawi, Mothaffar F.
Specht, Jennifer M.
Storniolo, Anna Maria
Valero, Vicente
Vaklavas, Chris
Winer, Eric P.
Krop, Ian E.
Wolff, Antonio C.
Wahl, Richard L.
Thompson, E. Aubrey
Stearns, Vered
Perou, Charles
Carey, Lisa A.
Connolly, Roisin M.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)